ERGO.L Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (10 nov 2023 @ 17:29):

Stats
Dagens volum	33 234.00
Gjennomsnittsvolum	922 955
Markedsverdi	771.71M
EPS	£0 ( 2024-03-18 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	48.14
ATR14	£15.31 (1.14%)

Volum Korrelasjon

Lang: 0.36 (neutral)

Kort: 0.07 (neutral)

Signal:(66.053) Neutral

Ergomed PLC Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Ergomed PLC Korrelasjon - Valuta/Råvare

0.86
( strong )

0.55
( weak )

0.52
( weak )

0.58
( weak )

-0.75
( moderate negative )

Ergomed PLC Økonomi

Annual	2022
Omsetning:	£145.26M
Bruttogevinst:	£59.15M (40.72 %)
EPS:	£0.300

FY	2022
Omsetning:	£145.26M
Bruttogevinst:	£59.15M (40.72 %)
EPS:	£0.300

FY	2021
Omsetning:	£118.58M
Bruttogevinst:	£48.36M (40.78 %)
EPS:	£0.260

FY	2020
Omsetning:	£86.39M
Bruttogevinst:	£39.65M (45.90 %)
EPS:	£0.200

Financial Reports:

No articles found.

Ergomed PLC

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. It focuses on various therapeutic areas, including oncology, haematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. The company also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.